Coronavirus Vaccine Updates | Bharat Biotech hits outs at critics, says carried out ‘200 pc honest’ trials of corona vaccine | Covid-19 Vaccine News | On the statement of Poonawala, MD of Bharat Biotech said – AstraZeneca gave paracetamol to suppress the side effects of the vaccine.

Fed up with Ads? Install Dainik Bhaskar app for news without ads

The two big pharma companies, which have received emergency use of the Corona vaccine in the country, have clashed. Krishna Biyala, MD, Bharat Biotech, said on Monday, without naming Adar Poonawala of Serum Institute, “Some companies have described my product as water.” I reject it. We are scientists.

Alla further questioned the trial of AstraZeneca. Said- AstraZeneca gave paracetamol to the volunteers with the vaccine, to suppress the adverse reaction of the vaccine.

Earlier, Adar Poonawalla, CEO of Serum Institute of India (SII), on Sunday described all other vaccines as water except Pfizer, Moderna and Oxford-AstraZeneca’s Covishield.

We do 200% honest trial
MD of Bharat Biotech said, ‘We do clinical trials 200% honestly. Despite this, we get to hear negative things from people. If I am wrong then tell me. Trials in our vaccine have seen less than 10% side effects, while other vaccines have 60 to 70% side effects. ‘

Indigenous Vaccine No Less Than Pfizer
Ella said, ‘Our vaccine is no less than Pfizer’s vaccine. Look at Pfizer. He has 5 publications of vaccine data. Bharat Biotech also has 5 publications. We are no less than Pfizer in terms of data publication.

We have experience and research
He said, ‘I think that we are the only company, which has rich research experience and peer reviewed journals. Many people say that there is no transparency in our data. Such people should be patient and read our articles on the Internet. Those people should see what our articles are like.

He said that Bharat Biotech had identified the most zika virus. We were the first to apply for a global patent for the vaccine of Zika and Chikungunya.

Opposition raised questions on Kovaxin
Samajwadi Party President Akhilesh Yadav first questioned Kovacsin. Congress leader Rashid Alvi supported Akhilesh. After this, Congress leader Shashi Tharoor said that Kovaxin has not yet completed its third trial. The vaccine is approved in a hurry and can be dangerous.

Government responded to the opposition
On the allegations of opposition, Union Health Minister Dr. Harsh Vardhan said that doing politics on such serious issues is quite disappointing. Shashi Tharoor, Akhilesh Yadav and Jairam Ramesh do not try to question the protocol adopted to approve the vaccine.

Kovaxin and Kovyshield received approval
The Indigenous Kovaxin and Serum Institute’s Kovashield’s Emergency Use of India Biotech was approved by the Drugs Controller General of India (DCGI) on Sunday. At the same time, Zaykov-D of Zydus Cadila Healthcare has received the approval of Phase-3 trial.